(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-12,13-dihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-7-methoxy-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione; 6-O-Methylerythromycin; 6-O-Methylerythromycin A; A 56268; Abbott 56268; Antibiotic A 56268; Antibiotic TE 31; BIAXIN XL; Biaxin; CRIXAN OD; Clamicin; Claric; Claris; Claritek; Clarith; Clarithro; Clarithromycin; Clathromycin; Crixan; Fascar; Fromilid; Kelamycin; Klacid; Klaribac; Klaricid; Klarithran MR; Macladin; Naxy; TE 031; Veclam; Zeclar
Clarithromycin is a fully characterized chemical compound used as a reference standard of API Clarithromycin. The standard offered is compliant with regulatory guidelines. Clarithromycin is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 81103-11-9
Related products
Clarithromycin EP Impurity D (N-Desmethyl Clarithromycin)
M.F.
M.W. 733.94
CAT# AR-C03024
CAS# 101666-68-6
Clarithromycin EP Impurity G (Mixture of Z and E Isomers)
M.F.
M.W. 777.01
CAT# AR-E00998
CAS# 107216-09-1
N-(3-Desethynylphenyl)-N-(3-bromophenyl) Erlotinib Hydrochloride
M.F.
M.W. 448.31 36.5
CAT# AR-E02315
CAS# 2055840-41-8
